News Center
We are pleased to announce the signing of an agreement on March 11, 2025, to acquire the assets of the Life Science unit of Voden Medical Instruments S.p.A. This unit focuses on diagnostics, cellular and molecular biology as well as genome analysis and distributes our GenDx line of products in Italy. These strategic acquisitions strengthen […]
As of March 1st, 2025, Eurobio Scientific Group has successfully completed the acquisition of Quimark SRL, our trusted distributor of 𝐄𝐧𝐝𝐨𝐏𝐫𝐞𝐝𝐢𝐜𝐭® and 𝐏𝐫𝐨𝐥𝐚𝐫𝐢𝐬® in Italy. This strategic step strengthens our presence in the Italian market and reaffirms our commitment to providing innovative oncology solutions to patients and healthcare professionals. We look forward to this new
Eurobio Scientific Group has successfully completed the acquisition of Quimark SRL Mehr lesen "
Eurobio Scientific has signed a strategic agreement with Biovica, a company specializing in cancer monitoring, to distribute DiviTum® TKa in key European markets, including DACH, UK, FR and Benelux. This collaboration covers 60% of the European market potential and strengthens Eurobio Scientific’s oncology diagnostics offering. DiviTum® TKa is a blood-based biomarker test that monitors and predicts
Eurobio Scientific erweitert sein Onkologie-Portfolio durch Partnerschaft mit Biovica Mehr lesen "
Diese Datenschutzerklärung informiert Sie über die Art und Weise, in der Eurobio Scientific als für die Verarbeitung Verantwortlicher im Sinne der Bestimmungen der Allgemeinen Datenschutzverordnung Nr. 2016/679 vom 27. April 2016 ("GDPR") und des Datenschutzgesetzes Nr. 78-17 vom 6. Januar 1978 (nachfolgend zusammen als "Verordnungen" bezeichnet) personenbezogene Daten über Sie über seine Website www.eurobio-scientific.com (nachfolgend die Website) sammelt und verarbeitet.